| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |